|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sleeman JP, Nazarenko I and Thiele W: Do
all roads lead to Rome? Routes to metastasis development. Int J
Cancer. 128:2511–2526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collado M and Serrano M: Senescence in
tumours: Evidence from mice and humans. Nat Rev Cancer. 10:51–57.
2010. View
Article : Google Scholar
|
|
5
|
Klein CA: Parallel progression of primary
tumours and metastases. Nat Rev Cancer. 9:302–312. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta GP, Minn AJ, Kang Y, Siegel PM,
Serganova I, Cordón-Cardo C, Olshen AB, Gerald WL and Massagué J:
Identifying site-specific metastasis genes and functions. Cold
Spring Harb Symp Quant Biol. 70:149–158. 2005. View Article : Google Scholar
|
|
7
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chopra B, Dhingra AK and Dhar KL: Psoralea
corylifolia L. (Buguchi) - folklore to modern evidence: Review.
Fitoterapia. 90:44–56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Hong C, Zhou C, Xu D and Qu HB:
Screening antitumor compounds psoralen and isopsoralen from
Psoralea corylifolia L. seeds. Evid Based Complement Alternat Med.
2011:3630522011.
|
|
10
|
Latha PG, Evans DA, Panikkar KR and
Jayavardhanan KK: Immunomodulatory and antitumour properties of
Psoralea corylifolia seeds. Fitoterapia. 71:223–231. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang SY, Gruber J, Wong KP and Halliwell
B: Psoralea corylifolia L. inhibits mitochondrial complex I and
proteasome activities in SH-SY5Y cells. Ann NY Acad Sci.
1100:486–496. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen MC, Chang WW, Kuan YD, Lin ST, Hsu HC
and Lee CH: Resveratrol inhibits LPS-induced epithelial-mesenchymal
transition in mouse melanoma model. Innate Immun. 18:685–693. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim A, Im M and Ma JY: Anisi stellati
fructus extract attenuates the in vitro and in vivo metastatic and
angiogenic potential of malignant cancer cells by downregulating
proteolytic activity and pro-angiogenic factors. Int J oncol.
45:1937–1948. 2014.PubMed/NCBI
|
|
14
|
Liu YC, Chiang IT, Hsu FT and Hwang JJ:
Using NF-κB as a molecular target for theranostics in radiation
oncology research. Expert Rev Mol Diagn. 12:139–146. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mulholland DJ, Kobayashi N, Ruscetti M,
Zhi A, Tran LM, Huang J, Gleave M and Wu H: Pten loss and RAS/MAPK
activation cooperate to promote EMT and metastasis initiated from
prostate cancer stem/progenitor cells. Cancer res. 72:1878–1889.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM
and Zhou BP: Stabilization of snail by NF-kappaB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Whelan LC and Ryan MF: Ethanolic extracts
of Euphorbia and other ethnobotanical species as inhibitors of
human tumour cell growth. Phytomedicine. 10:53–58. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu CZ, Cai XF, Dat NT, Hong SS, Han AR,
Seo EK, Hwang BY, Nan JX, Lee D and Lee JJ: Bisbakuchiols A and B,
novel dimeric meroterpenoids from Psoralea corylifolia. Tetrahedron
Lett. 48:8861–8864. 2007. View Article : Google Scholar
|
|
22
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nguyen PT, Kudo Y, Yoshida M, Kamata N,
Ogawa I and Takata T: N-cadherin expression is involved in
malignant behavior of head and neck cancer in relation to
epithelial-mesenchymal transition. Histol Histopathol. 26:147–156.
2011.
|
|
24
|
Araki K, Shimura T, Suzuki H, Tsutsumi S,
Wada W, Yajima T, Kobayahi T, Kubo N and Kuwano H: E/N-cadherin
switch mediates cancer progression via TGF-β-induced
epithelial-to-mesenchymal transition in extrahepatic
cholangiocarcinoma. Br J Cancer. 105:1885–1893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang J, Xiao D, Li G, Ma J, Chen P, Yuan
W, Hou F, Ge J, Zhong M, Tang Y, et al: EphA2 promotes
epithelial-mesenchymal transition through the Wnt/β-catenin pathway
in gastric cancer cells. Oncogene. 33:2737–2747. 2014. View Article : Google Scholar
|
|
26
|
Yan D, Avtanski D, Saxena NK and Sharma D:
Leptin-induced epithelial-mesenchymal transition in breast cancer
cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1
protein-dependent pathways. J Biol Chem. 287:8598–8612. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Z, Chen L, Zhang X, Xu X, Xing H,
Zhang Y, Li W, Yu H, Zeng J and Jia J: RUNX3 regulates vimentin
expression via miR-30a during epithelial-mesenchymal transition in
gastric cancer cells. J Cell Mol Med. 18:610–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu K, Zeng J, Li L, Fan J, Zhang D, Xue Y,
Zhu G, Yang L, Wang X and He D: Silibinin reverses
epithelial-to-mesenchymal transition in metastatic prostate cancer
cells by targeting transcription factors. Oncol Rep. 23:1545–1552.
2010.PubMed/NCBI
|
|
29
|
Xiao LJ, Chen YY, Lin P, Zou HF, Lin F,
Zhao LN, Li D, Guo L, Tang JB, Zheng XL, et al: Hypoxia increases
CX3Cr1 expression via HIF-1 and NF-κB in androgen-independent
prostate cancer cells. Int J Oncol. 41:1827–1836. 2012.PubMed/NCBI
|
|
30
|
Ennen M, Klotz R, Touche N, Pinel S,
Barbieux C, Besancenot V, Brunner E, Thiebaut D, Jung AC,
Ledrappier S, et al: DDB2: A novel regulator of NF-κB and breast
tumor invasion. Cancer Res. 73:5040–5052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar
|
|
32
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
